终末期肝病模型（MELD）是目前被广泛认可的评估终末期肝病严重程度的评分体系。
The model for end-stage liver disease (MELD) score is a prospectively developed and validated scale for the severity of end-stage liver disease.
目的：探讨MELD评分(终末期肝病模型)在评价行肝移植手术患者围手术期营养状况中的应用价值。
Objective: To investigate the clinical value of MELD (model for end-stage liver disease) score for evaluation of perioperative nutrition status liver transplantation candidates.
探讨终末期肝病模型(MELD)评分系统对预测慢性重型乙型病毒性肝炎患者短期预后的临床应用价值。
To assess the value of the model for end-stage liver disease (MELD) on the short-term prognosis in the patients with chronic liver failure (chronic and severe hepatitis B).
目的通过观察终末期肝病模型(MELD)在终末期肝病预后预测中的作用，探讨其在临床的应用价值及人工肝支持系统在终末期肝病治疗中的效果。
Objective: To study the practical use of model end-stage liver disease (MELD) on clinic and the role of artificial liver support system (ALSS) on end-stage liver disease.
目的评价分子吸附再循环系统(MARS)治疗重型肝炎的临床疗效，应用终末期肝病评分模型(MELD)，观察它对重型肝炎预后的预测作用。
Objective to evaluate the efficiency of Molecular Adsorbents Recycling System (MARS) in the treatment of severe hepatitis and to study the clinical use of the Model for End-Stage Liver Diease (MELD).
目的：应用MELD(终末期肝病评分模型)评价慢性重型肝炎的近期预后。
Objective: To evaluate the application of the Model for End-Stage Liver Disease (MELD) in predicting the short-term prognosis in patients with chronic severe viral hepatitis.
目的：应用MELD(终末期肝病评分模型)评价慢性重型肝炎的近期预后。
Objective: To evaluate the application of the Model for End-Stage Liver Disease (MELD) in predicting the short-term prognosis in patients with chronic severe viral hepatitis.
应用推荐